174 related articles for article (PubMed ID: 17031405)
21. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer.
Chang KJ; Soetikno RM; Bastas D; Tu C; Nguyen PT
Endoscopy; 2003 Nov; 35(11):962-6. PubMed ID: 14606021
[TBL] [Abstract][Full Text] [Related]
22. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
23. Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation.
Bergquist H; Johnsson A; Hammerlid E; Wenger U; Lundell L; Ruth M
Aliment Pharmacol Ther; 2008 Mar; 27(5):385-95. PubMed ID: 18081735
[TBL] [Abstract][Full Text] [Related]
24. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
Hayashi Y; Xiao L; Suzuki A; Blum MA; Sabloff B; Taketa T; Maru DM; Welsh J; Lin SH; Weston B; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Ajani JA
Eur J Cancer; 2012 Dec; 48(18):3396-404. PubMed ID: 22853875
[TBL] [Abstract][Full Text] [Related]
25. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden.
Sridhar P; Bhatt M; Qureshi MM; Asokan S; Truong MT; Suzuki K; Mak KS; Litle VR
Ann Thorac Surg; 2019 May; 107(5):1472-1479. PubMed ID: 30605641
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.
Bascoul-Mollevi C; Gourgou S; Galais MP; Raoul JL; Bouché O; Douillard JY; Adenis A; Etienne PL; Juzyna B; Bedenne L; Conroy T
Eur J Cancer; 2017 Oct; 84():239-249. PubMed ID: 28829992
[TBL] [Abstract][Full Text] [Related]
27. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography-computed tomography in oesophageal cancer staging: a tailored approach.
Bunting DM; Lai WW; Berrisford RG; Wheatley TJ; Drake B; Sanders G
World J Surg; 2015 Apr; 39(4):1000-7. PubMed ID: 25446482
[TBL] [Abstract][Full Text] [Related]
30. Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.
Thomas M; Borggreve AS; van Rossum PSN; Perneel C; Moons J; Van Daele E; van Hillegersberg R; Deng W; Pattyn P; Mook S; Boterberg T; Ruurda JP; Nafteux P; Lin SH; Haustermans K
Acta Oncol; 2019 Oct; 58(10):1358-1365. PubMed ID: 31432736
[No Abstract] [Full Text] [Related]
31. Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
van Putten M; Koëter M; van Laarhoven HWM; Lemmens VEPP; Siersema PD; Hulshof MCCM; Verhoeven RHA; Nieuwenhuijzen GAP
Ann Surg; 2018 Feb; 267(2):303-310. PubMed ID: 27811508
[TBL] [Abstract][Full Text] [Related]
32. Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009: a survey in the Netherlands.
Homs MY; van Oijen MG; Wijnhoven BP; van Hillegersberg R; de Boer-Dennert M; Siersema PD
Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):126-33. PubMed ID: 22113210
[TBL] [Abstract][Full Text] [Related]
33. Oesophageal carcinoma.
Pennathur A; Gibson MK; Jobe BA; Luketich JD
Lancet; 2013 Feb; 381(9864):400-12. PubMed ID: 23374478
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
[TBL] [Abstract][Full Text] [Related]
35. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
36. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
37. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.
Deng HY; Wang WP; Wang YC; Hu WP; Ni PZ; Lin YD; Chen LQ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):421-431. PubMed ID: 27694253
[TBL] [Abstract][Full Text] [Related]
39. [Oesophageal cancer: what's new during the last 10 years?].
Triboulet JP; Mariette C
Bull Cancer; 2008 Apr; 95(4):425-31. PubMed ID: 18495572
[TBL] [Abstract][Full Text] [Related]
40. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
